Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Systemic immune-inflammation index (SII), based on peripheral lymphocyte, neutrophil, and platelet counts, was recently investigated as a prognostic marker in several tumors. However, SII has not been reported in esophageal squamous cell carcinoma (ESCC). We evaluated the prognostic value of the SII in 916 patients with ESCC who underwent radical surgery. Univariate and multivariate analyses were calculated by the Cox proportional hazards regression model. The time-dependent receiver operating characteristics (ROC) curve was used to compare the discrimination ability for OS. PSM (propensity score matching) was carried out to imbalance the baseline characteristics. Our results showed that SII, PLR, NLR and MLR were all associated with OS in ESCC patients in the Kaplan-Meier survival analysis. However, only SII was an independent risk factor for OS (HR = 1.24, 95% CI 1.01–1.53, P = 0.042) among these systemic inflammation scores. The AUC for SII was bigger than PLR, NLR and MLR. In the PSM analysis, SII still remained an independent predictor for OS (HR = 1.30, CI 1.05–1.60, P = 0.018). SII is a novel, simple and inexpensive prognostic predictor for patients with ESCC undergoing radical esophagectomy. The prognostic value of SII is superior to PLR, NLR and MLR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Camp, R. L., Dolled-Filhart, M., & Rimm, D. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0713 · Cited by 3,744
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0442 · Cited by 2,493
Pennathur, A., Gibson, M. K., Jobe, B. A., & Luketich, J. D. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60643-6 · Cited by 2,390
Cancer-related inflammation and treatment effectiveness
Diakos, C. I., Charles, K. A., McMillan, D. C., & Clarke, S. J. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70263-3 · Cited by 2,193
Cited by
Items 101–200 of 234
Gao, X., Ma, K.-L., Wang, H., Gao, Q., Lei, L., & Wang, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-45329-2 · Cited by 20
Shang, Q.-X., Yang, Y., Hu, W., Yuan, Y., He, Y., Zhao, J., Ji, A., & Chen, L.-Q. (2020) · Translational Cancer Research · doi:10.21037/tcr-19-2777 · Cited by 19
Li, X., Hu, P., Liu, J., Zhang, J., & Liu, Q. (2020) · Future Oncology · doi:10.2217/fon-2019-0761 · Cited by 22
Akpınar, Ç. K., Kocatürk, Ö., Aykaç, Ö., Acar, B. A., Dogan, H. S., Önalan, A., Acar, T., Kocabaş, Z. U., TOPAKTAŞ, B., Gürkaş, E., et al. (2023) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2023.107856 · Cited by 17
Gong, J., Zhou, W., Xiao, C., Jie, Y., Zhu, S., Zheng, J., Chong, Y., & Hu, B. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.12.018 · Cited by 17
Self-citationÖzkan, E. E., KAYMAK, Z. A., & Erdogan, M. (2020) · The Clinical Respiratory Journal · doi:10.1111/crj.13217 · Cited by 17
Tong, H., Feng, H., Hu, X., Wang, M., Song, Y., Wen, X., Li, Y., & Wan, X. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.544248 · Cited by 18
Zhang, Y., Chen, Z., Jin, F., Guo, D. L., Chen, Q., Liu, Z., Ji, S., & Gao, G.-Q. (2021) · Mediators of Inflammation · doi:10.1155/2021/2910892 · Cited by 19
Zhu, X., Zhang, K.-J., Li, X., Su, F., & Tian, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-53540-z · Cited by 16
“In a recent study, Geng and colleagues found that the Systemic Immune-Inflammation Index (SII) has a better prognostic value than the Ratio of Neutrophils to Lymphocytes (RNL) and the Ratio of Platelets to Lymphocytes (RPL) 44 .”
BackgroundKošec, A., Solter, D., Ribić, A., Knežević, M., Vagić, D., & Pegan, A. (2021) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2021.12.011 · Cited by 16
Tian, T., Xie, M., & Sun, G. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1400484 · Cited by 16
Zhao, Y., Bai, Y. P., & Li, L. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.70050 · Cited by 15
“Recent research has revealed a novel indicator for inflammation and immunity i.e. low ‐ cost and accessible: the systemic immune ‐ inflammation index (SII index) [16, 18, 35, 36].”
BackgroundLiu, F., Ran, Q., Zhang, H., & Chen, J. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020403 · Cited by 19
Yao, J., Shao, Y., Wang, J., Li, Y.-L., Yang, H., Liu, J., & Yang, Y. F. (2021) · Journal of Cancer · doi:10.7150/jca.51972 · Cited by 18
“In recent years, as a novel index, the systemic immune-inflammation index (SII) has come to be considered as a better indicator of systemic immuneinflammatory status compared to traditional indexes, such as the neutrophil-lymphocyte ratio or plateletlymphocyte ratio, and some studies have found an adverse association…”
BackgroundSelf-citationHuang, T., Zhang, H., Zhao, Y., Li, Y., Wang, G., Zhang, Y., Guo, D. L., Ji, S., & Sun, Z. (2021) · Future Oncology · doi:10.2217/fon-2020-1272 · Cited by 16
Lin, C., Lin, S., Guo, Q., Zong, J., Lu, T., Lin, N., Lin, S.-J., & Pan, J.-J. (2019) · Translational Cancer Research · doi:10.21037/tcr.2019.09.25 · Cited by 15
Zhang, X., Wang, Y., Zhao, L., Sang, S., & Zhang, L. (2018) · The International Journal of Biological Markers · doi:10.1177/1724600818766889 · Cited by 15
Lee, M., Lee, E. J., Kim, R. O., Pyun, J., Joo, B., Kwon, K., Roh, H., Ahn, M., & Lee, K. B. (2024) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2024.108182 · Cited by 15
Qiu, L., Ren, Y., Li, J., Li, M., Li, W., Qin, L., Ning, C., Zhang, J., & Gao, F. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.06.003 · Cited by 14
Ju, Q., Huang, T., Zhang, Y., Wu, L., Geng, J., Mu, X., Yan, T., & Zhang, J. (2021) · Medicine · doi:10.1097/md.0000000000024640 · Cited by 16
“Previous studies have demonstrated that the SII plays the vital role of a marker for predicting survival and recrudescence in various tumors, such as esophageal cancer,([16]) hepatocellular carcinoma,([15]) pancreatic cancer,([17]) and prostate cancer.”
BackgroundBilir, F., Chkhikvadze, M., Yilmaz, A. Y., Köse, O., & Arıöz, D. T. (2022) · Ginekologia Polska · doi:10.5603/gp.a2021.0200 · Cited by 14
Peng, L., Luo, X., Cao, B., & Wang, X. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304591 · Cited by 20
Li, J., Wang, Z., Li, A., Zhou, H., & Zhu, X. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100818 · Cited by 13
Kirupakaran, A. M., Yadav, K. S., Misra, S., Khan, T., Bhuyan, M. K., & Laskar, R. H. (2020) · IET Image Processing · doi:10.1049/ipr2.12095 · Cited by 13
Oğuz, E. G., Yeter, H. H., Akçay, Ö. F., Besli, S., Selen, T., Derici, Ü., Şencan, İ., & Aylı, M. D. (2022) · Hemodialysis International · doi:10.1111/hdi.13001 · Cited by 13
“Furthermore, Geng et al suggested that SII was superior to the NLR, and served as a more objective marker that reflects the balance between host inflammatory and immune response status in patient with esophageal cancer.(25) However, there are no enough data representative of the general population or patient groups ot…”
BackgroundDolu, A. K., Akçay, F. A., Atalay, M., & Karaca, M. (2023) · The Journal of Tehran University Heart Center · doi:10.18502/jthc.v18i2.13317 · Cited by 15
(2024) · doi:10.4149/bll_2024_73 · Cited by 12
Zhang, Y., Wu, W., & Zhang, Z. (2023) · Toxicon · doi:10.1016/j.toxicon.2023.107269 · Cited by 12
Committeri, U., Barone, S., Arena, A., Fusco, R., Troise, S., Maffìa, F., Tramontano, S., Bonavolontà, P., Abbate, V., Granata, V., et al. (2024) · Journal of Stomatology Oral and Maxillofacial Surgery · doi:10.1016/j.jormas.2024.101912 · Cited by 13
Chen, K., Wang, L., Ning, H., Pan, H., & Zhang, W. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1552451 · Cited by 17
Li, J., Shao, J., Zhang, X., Chen, X., Zhao, W., Qian, H., Cui, X., & Jiang, X. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/8781674 · Cited by 12
Li, S., Chen, D., Li, S., Zhao, Z., Yang, H., Wang, D., Zhang, Z., & Fu, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.581855 · Cited by 12
Wu, J., Zhu, H., Zhang, Q., Sun, Y., He, X., Liao, J., Liu, Y., & Huang, L. (2022) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.13806 · Cited by 15
Ryvlin, J., Kim, S. W., Hamad, M., Fourman, M. S., Eleswarapu, A. S., Murthy, S. G., Gelfand, Y. J., Ramos, R. D. L. G., & Yassari, R. (2023) · Journal of Neurosurgery Spine · doi:10.3171/2023.10.spine23851 · Cited by 12
Wen, Z., Liu, X., & Zhang, T. (2024) · Scientific Reports · doi:10.1038/s41598-024-64050-3 · Cited by 12
Inagaki, K., Kanda, M., Nakanishi, K., Ito, S., Mochizuki, Y., Teramoto, H., Ishigure, K., Murai, T., Asada, T., Ishiyama, A., et al. (2021) · World Journal of Surgery · doi:10.1007/s00268-021-06138-9 · Cited by 11
“Hypoalbuminemia is associated with not only malnutrition but also persistent systemic inflammation, increasing noncancer-related and cancer-related deaths [9, 20].”
BackgroundKaraüzüm, K., Karaüzüm, İ., Hanci, K., Gökçek, M. D., Gunay, B., Bakhshian, H., Şahin, T., & Ural, E. (2022) · Cardiology Research and Practice · doi:10.1155/2022/7344639 · Cited by 12
Lu, Y., Zhang, Z., Gao, S., Yan, H., Zhang, L., & Liu, J. (2020) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-020-01587-6 · Cited by 12
Kim, T.-G., Sim, J., Hong, S. Y., & Kim, B. (2021) · Transplantation Proceedings · doi:10.1016/j.transproceed.2021.09.039 · Cited by 12
Ata, Y., & Abanoz, M. (2021) · The Heart Surgery Forum · doi:10.1532/hsf.4279 · Cited by 11
Geller, V., & Dominiak, M. (2025) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/205833 · Cited by 12
Zhong, L., Zhan, X., & Luo, X. (2023) · Medicine · doi:10.1097/md.0000000000035724 · Cited by 12
“[19] Lymphocytes and neutrophils mediate adaptive and innate immunity, respectively.”
BackgroundZhang, L., Lu, A.-X., Li, J., Li, J., Xu, X., Yan, C., & Zhong, L. (2024) · Pediatric Research · doi:10.1038/s41390-024-03472-1 · Cited by 10
Shen, G., He, H., Zhang, X., Wang, L., Wang, Z., Li, F., Lü, Y., & Li, W. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03762-3 · Cited by 11
Gao, H., Wusiman, L., Cao, B.-W., Wujieke, A., & Zhang, W. (2022) · Transplant Immunology · doi:10.1016/j.trim.2022.101613 · Cited by 10
Rovesti, G., Leone, F., Brandi, G., Fornaro, L., Scartozzi, M., Niger, M., Yoo, C., Caputo, F., Filippi, R., Casagrande, M., et al. (2021) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-021-00596-z · Cited by 10
Zhang, P., Wang, S., Wu, J., & Song, Q. (2023) · BMC Cancer · doi:10.1186/s12885-023-10804-7 · Cited by 10
Luo, Y., Deng, R., Zhong, Q., Luo, D., Li, X., Chen, X., Tao, S., Feng, Z., Jiayi, L., Huang, Y., et al. (2021) · Medicine · doi:10.1097/md.0000000000026437 · Cited by 10
Kazlow, E., Rinawi, E., Gerszman, E., Mattar, S., Essami, N., Nasir, M., Shtaya, A. A., Assaf, W., Haddad, R., & Mahamid, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113762 · Cited by 9
“…index (SII), another inflammatory biomarker [calculated as (absolute platelet count × absolute neutrophil count)/lymphocyte count], has shown to have significant prognostic value in several types of cancer, including pancreatic cancer, renal cell carcinoma, and gastro-esophageal cancer [15–18].”
Çelik, M., Çiftçi, M. U., Çelik, S., Öztürk, V., Bayrak, A., Duramaz, A., Kural, A., & Kural, C. (2024) · International Orthopaedics · doi:10.1007/s00264-024-06190-9 · Cited by 9
Fu, Z., Cheng, P., Qian, J., Wang, H., & Ma, Y. (2023) · Digestive Diseases · doi:10.1159/000532110 · Cited by 7
Liu, S., Li, Z., Guo, W., Liu, Z., & Fan, Y. (2023) · Medical Science Monitor · doi:10.12659/msm.940041 · Cited by 7
“At the same time, the NLR, PLR, and MLR have gradually become predictive factors to evaluate the severity of disease [21-25].”
BackgroundLiu, Z., Lv, D., Li, J., Li, F., Zhang, Y., Liu, Y., Gao, C., Qiu, Y., Ma, J., & Zhang, R. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1431350 · Cited by 7
Wier, J. R., Jones, I. A., Palmer, R. C., Mayfield, C. K., Kassebaum, N. J., Lieberman, J. R., & Heckmann, N. D. (2024) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.24.00184 · Cited by 8
Association between TyG-BMI and early-onset hypertension: evidence from NHANES
Li, W., Ge, C., & Zhou, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-92159-6 · Cited by 7
Jia, M., Han, S., & Wang, Y. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2385059 · Cited by 6
“Numerous studies have verified its high prognostic value in various tumors, including lung cancer [38], esophageal cancer [39], and epithelial ovarian cancer [40].”
BackgroundMora, A., Nakajima, Y., Okada, T., Tokairin, Y., Kawada, K., & Kawano, T. (2018) · Digestive Surgery · doi:10.1159/000486551 · Cited by 6
Prognostic impact of preoperative nutritional and immune inflammatory parameters on liver cancer
Bae, S. U. (2024) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v16.i2.266 · Cited by 5
Peripheral immune cell markers and cognitive function in patients with schizophrenia
Karahan, A., Saka, I. M., Aykut, D. S., Arslan, F. C., Özmen, E. S., & Karagüzel, E. Ö. (2024) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174241266059 · Cited by 6
Individualized physical training in the therapy of Primary Ciliary Dyskinesia – A case report
Schumann, M., Freitag, N., Haag, E., & Bloch, W. (2019) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2019.100925 · Cited by 5
Morkavuk, Ş. B., Çulcu, S., Esen, E., & Ünal, A. E. (2021) · World Journal of Surgical Oncology · doi:10.1186/s12957-021-02437-6 · Cited by 5
Göğer, Y. E., Özkent, M. S., Karaağaç, M., Uçmak, H., & Artaç, M. (2021) · Bulletin of Urooncology · doi:10.4274/uob.galenos.2021.2021.3.2 · Cited by 5
Öztürk, S., Erdoğan, M., & Turan, Y. (2021) · Acta Medica Alanya · doi:10.30565/medalanya.936506 · Cited by 5
Ali, S. Y., Sadik, M. I., Seid, A. M., Mohammed, A. H., Yimam, A. A., Shegere, M. M., Ayele, T. S., Wako, A. J., & Ibrahim, M. M. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1454793 · Cited by 4
Yao, Y., Cai, C., Sun, F., & Gong, W. (2021) · Cancer Management and Research · doi:10.2147/cmar.s325219 · Cited by 4
“Multivariate analysis showed that the APS was an independent prognostic factor for patients with ESCC.”
BackgroundMethodInfluentialAwaji, K., Miyagawa, T., Omatsu, J., Numajiri, H., Kawai, T., Funamizu, K., Saigusa, R., Yamada, D., Asano, Y., & Sato, S. (2021) · Acta Dermato Venereologica · doi:10.2340/00015555-3898 · Cited by 4
Cui, C., Wu, X., Deng, L., Wang, W., Cui, W., & Wang, Y. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14486 · Cited by 4
Balbaloĝlu, H., Taşdöven, İ., & Cakmak, G. K. (2023) · Medicine · doi:10.1097/md.0000000000034808 · Cited by 5
Crocetto, F., Imbimbo, C., Barone, B., Turchino, D., Bracale, U. M., Peluso, A., Panagrosso, M., Falcone, A., Mirto, B. F., Luca, L. D., et al. (2023) · Basic and Clinical Andrology · doi:10.1186/s12610-023-00213-y · Cited by 5
Chen, W., Tang, M., Chen, D., Zhou, Y., Liang, G., Shen, R., & Chen, T. (2024) · Cancer Medicine · doi:10.1002/cam4.70264 · Cited by 4
“The systemic immune-inflammation index (SII), encompassing platelets, neutrophils, and lymphocytes, offers a comprehensive reflection of a patient's inflammatory and immune status and may surpass NLR, PLR, and MLR in predictive accuracy [10–12].”
BackgroundKumbul, Y. Ç., Yasan, H., Tüz, M., Okur, E., Sivrice, M. E., & Büyükçelik, B. (2020) · SDÜ Tıp Fakültesi Dergisi · doi:10.17343/sdutfd.742573 · Cited by 4
Wu, W., Zhang, L., Wang, C., Xu, Z., Feng, C., Zhang, Z., Qin, D., Zhang, C., & Lin, F. (2023) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2023.06.068 · Cited by 4
Xiao, Y., Jiang, C., Li, H., Xu, D., Liu, J., Huili, Y., Nie, S., Guan, X., & Cao, F. (2023) · Translational Cancer Research · doi:10.21037/tcr-23-1183 · Cited by 4
“A study of 440,000 samples found that higher SII, NLR, and PLR scores were associated with a greater risk of kidney cancer, while the LMR showed the opposite (10).”
Ou, Y., Li, X., Zheng, Y., Hu, X., Bao, Y., Wang, D., Chen, Z., & Ren, S. (2024) · BMC Surgery · doi:10.1186/s12893-024-02496-y · Cited by 3
“Since then, a large number of studies have found that SII can effectively predict the prognosis of various malignant tumors, such as non-small cell lung cancer, colorectal cancer, gastric cancer, esophageal squamous cell carcinoma, and pancreatic cancer [32–34].”
BackgroundZhang, T., Wang, J., Wang, D., Xu, K., Wu, L., Wang, X., Wang, W., Deng, L., Liang, J., Lv, J., et al. (2021) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2021.11.003 · Cited by 3
Kubo, Y., Fujita, T., Sato, K., Kajiyama, D., Kubo, K., & Daiko, H. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-17489-1 · Cited by 3
“10,11 Inflammation in the tumor microenvironment may promote or inhibit tumor progression depending on the types of immune cells and their interactions with the tumor and other stromal cells.”
Shahin, M. M., Allam, A. A., Elkholy, R. A., & Lashin, H. I. (2020) · Ain Shams Journal of Forensic Medicine and Clinical Toxicology · doi:10.21608/ajfm.2020.104446 · Cited by 4
ÇELİK, Ç. O., Özer, N., Çiftci, O., TORUN, Ş., Çolak, M. Y., & Müderrisoğlu, H. (2023) · Infectious Diseases and Clinical Microbiology · doi:10.36519/idcm.2023.171 · Cited by 3
“SII, defined as the platelet count x neutrophil count/lymphocyte count, had a high prognostic value in cancer patients (19).”
BackgroundToprak, M., Altıntaş, Ö., Sezer, Ö. Y., & Tuğan, B. Y. (2024) · Saudi Journal of Ophthalmology · doi:10.4103/sjopt.sjopt_170_24 · Cited by 3
Liu, Z., Liu, H., Zhang, Y., Yang, Y., & Gao, H. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s523882 · Cited by 2
Unkun, T., & Şengör, B. G. (2026) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250437 · Cited by 2
Hematological parameters in children with severe acute respiratory syndrome coronavirus 2 infection
Dobrijević, D., Vučković, B., Katanić, J., Rakić, G., Antić, J., & Čabarkapa, V. (2020) · Medicinski pregled · doi:10.2298/mpns2012337d · Cited by 2
“The SII, NLR and PLR are inflammation-related indicators [25, 26].”
BackgroundGezer, H. H., & Pehlivan, Ö. (2022) · Marmara medical journal · doi:10.5472/marumj.1186732 · Cited by 2
Blood-, Tissue- and Urine-Based Prognostic Biomarkers of Upper Tract Urothelial Carcinoma
Łaszkiewicz, J., Krajewski, W. R., Sójka, A., Nowak, Ł., Chorbińska, J., Subiela, J. D., Tomczak, W. A., Giudice, F. D., Małkiewicz, B., & Szydełko, T. (2024) · Diagnostics · doi:10.3390/diagnostics14171927 · Cited by 2
“The SII, which is based on the peripheral lymphocyte, neutrophil, and platelet counts, has been recently described as a cancer prognostic biomarker, reflecting the balance between inflammation and immune response [57,58].”
BackgroundZheng, M., Li, J., Cao, Y., Bao, Z., Dong, X., Zhang, P., Yan, J., Liu, Y., Guo, Y., & Zeng, X. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1490194 · Cited by 2
Chen, Z., Sun, L., Yu, X., & Zhang, Y. (2025) · PubMed Central · doi:10.6133/apjcn.202504_34(2).0009 · Cited by 2
Pellizzi, N., Mazzulla, A., Pagliusi, P., & Cipparrone, G. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.07.143 · Cited by 2
İncir, S. (2021) · International journal of medical biochemistry/International journal of medical biochemistry : · doi:10.14744/ijmb.2021.52523 · Cited by 2
“The SII, based on peripheral lymphocyte, neutrophil, and platelet counts, has been suggested as a better index of the local immune response and systemic inflammation because of its high prognostic value in various tumors [22, 23].”
Rovesti, G., Leone, F., Brandi, G., Cesario, S., Scartozzi, M., Niger, M., Yoo, C., Filippi, R., Casagrande, M., Silvestris, N., et al. (2021) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-021-00649-3 · Cited by 2
“, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, neutrophil-to-lymphocyte ratio), most likely being a better tool to comprehensively represent the interplay between immune response and host inflammatory status [18, 19].”
MethodPrognostic Value of Systemic Immune Index in Patients with Metastatic Gastric Cancer
Demir, H., Katırcılar, Y., Beypınar, İ., Eren, S. K., & İnanç, M. (2021) · European Archives of Medical Research · doi:10.4274/eamr.galenos.2020.36449 · Cited by 2
A Novel Scoring System in Predicting Prognosis After Adjuvant FOLFOX Chemotherapy in Gastric Cancer
Ge, G., Li, G., Zhang, Z., Zhu, Y., Wang, W., Ren, L., Li, Z., & Teng, M. (2022) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2021.0343 · Cited by 2
Küçük, A., ÖZTEP, Ş. E., Yılmaz, E. B., & Topkan, E. (2021) · Mersin üniversitesi sağlık bilimleri dergisi/Mersin üniversitesi sağlık bilimleri dergisi · doi:10.26559/mersinsbd.842266 · Cited by 3
Luo, P.-Q., Song, E.-D., Liu, F., Rankine, A. N., Zhang, L., Wei, Z., Han, W., & Xu, A. (2023) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v15.i1.49 · Cited by 1
苏比努尔, ·. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1381786 · Cited by 1
SÜLEYMAN, M., & Bezirci, R. (2023) · Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi · doi:10.20492/aeahtd.1342736 · Cited by 1
Censored imputation of time to event outcome through survival proximity score method
Vishwakarma, G. K., Bhattacherjee, A., Rajbongshi, B. K., & Tripathy, A. (2024) · Journal of Computational and Applied Mathematics · doi:10.1016/j.cam.2024.116103 · Cited by 1
Whole‐body‐electro‐myostimulation for the care of inclusion body myositis—A case report
Freitag, N., Dragutinovic, B., Notbohm, H. L., Filipovic, A., Schiffer, T., Bloch, W., & Schumann, M. (2024) · Clinical Case Reports · doi:10.1002/ccr3.9539 · Cited by 1
“25,26 Furthermore, CK, C—reactive protein and erythrocyte sedimentation rate was determined.”
MethodDu, Y., Chen, X., Song, J., Guo, Y., Liu, S., Liu, Z., & Li, J. (2025) · Discover Medicine · doi:10.1007/s44337-025-00230-y · Cited by 1
“…Ratio) [14], PLR (Platelet-Lymphocyte Ratio) [15], LMR (Lymphocyte-Monocyte Ratio) [16], SII (Systemic Immune-Inflammation Index) [17] and PNI (Prognostic Nutritional Index) [18], and preoperative variation of these indicators correlates with the prognosis of patients with…”
Serum elafin levels in patients with IgA vasculitis: a prospective case-control study
Zeybek, C., Bolat, A., Alpman, B. N., Karaoğlu, T. İ., Öner, N., & Güngörer, V. (2025) · Pediatric Rheumatology · doi:10.1186/s12969-025-01153-9 · Cited by 2
“Among systemic inflammatory markers, the SII is considered a more objective and comprehensive indicator of the balance between pro-inflammatory and immune responses than the PLR, NLR, or MLR [45].”
Miura, T., Kessoku, H., Nagaoka, M., Morishita, Y., Kobayashi, T., & Kojima, H. (2026) · Current Oncology · doi:10.3390/curroncol33010030 · Cited by 1
“Its prognostic utility has been confirmed across multiple cancer types [7,27–30], and it outperforms traditional inflammatory markers in both inflammation and prognosis, suggesting its potential as a cornerstone of tailored therapeutic approaches [26,31].”
Metadata
- Authors
- Geng, Y., Shao, Y., Zhu, D., Zheng, X., Zhou, Q., Zhou, W., Ni, X., Wu, C., & Jiang, J.
- Affiliations
- Soochow University (CN)
- Corresponding author
- Wu, Changping
- Jiang, Jingting
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-12-21
- Volume
- 6
- Issue
- 1
- Pages
- 39482-39482
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5175190
- OpenAlex
- W2563208071
- Cited by
- 233
- References
- 29
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 36 · 2023: 33 · 2022: 24 · 2021: 41 · 2020: 23 · 2019: 23 · 2018: 16 · 2017: 7
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (31570877, 81301960)
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- systemic immune-inflammation index, esophageal squamous cell carcinoma, prognostic factors, overall survival, radical esophagectomy, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, systemic inflammation, lymphocyte count, platelet count, neutrophil count
- MeSH terms
- Esophageal Squamous Cell Carcinoma, Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell, Esophageal Neoplasms, Female, Humans, Immunity, Inflammation, Male, Middle Aged, Prognosis, Regression Analysis, Retrospective Studies, Risk Factors, ROC Curve, Multivariate Analysis, Proportional Hazards Models, Esophagectomy, Kaplan-Meier Estimate, Propensity Score
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.